You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 11,357,738


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,357,738 protect, and when does it expire?

Patent 11,357,738 protects MIEBO and is included in one NDA.

This patent has eighteen patent family members in ten countries.

Summary for Patent: 11,357,738
Title:Semifluorinated compounds and their compositions
Abstract:The present invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye.
Inventor(s):Scherer Dieter, Grillenberger Ralf, Löscher Frank, Voss Hartmut
Assignee:NOVALIQ GMBH
Application Number:US16874617
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

United States Patent 11,357,738: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 11,357,738, titled "Semifluorinated compounds and their compositions," is a significant patent that focuses on the development and application of semifluorinated compounds, particularly for topical administration to the eye. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, assigned the publication number US11357738B2, was granted and is currently active. It stems from the patent application US16/874,617, which was filed to protect the innovative use of semifluorinated compounds in medical applications[1].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected. Here, the patent covers compositions comprising semifluorinated compounds designed for topical administration to the eye. This includes various formulations and methods of preparation that ensure the stability and efficacy of these compounds when applied to the eye.

Independent Claims

The independent claims are crucial as they define the broadest scope of the invention. For US Patent 11,357,738, these claims typically include:

  • The specific chemical structures of the semifluorinated compounds.
  • The methods of synthesizing these compounds.
  • The formulations and compositions that include these compounds.
  • The methods of topical administration to the eye[1].

Claim Analysis

Claim Length and Count

Research on patent claims suggests that the length and count of independent claims can be indicative of the patent's scope and quality. Patents with narrower claims, as measured by independent claim length (ICL) and independent claim count (ICC), tend to have a higher probability of grant and shorter examination processes. This implies that the claims in US Patent 11,357,738 are likely to be well-defined and specific, contributing to their validity and enforceability[3].

Claim Clarity and Breadth

The clarity and breadth of claims are critical for patent quality. The patent office tends to narrow the scope of patent claims during the examination process to ensure clarity and specificity. For US Patent 11,357,738, the claims would have undergone rigorous examination to ensure they are clear, specific, and not overly broad, which is essential for maintaining the integrity of the patent system[3].

Patent Landscape

Related Patents and Technologies

The patent landscape surrounding US Patent 11,357,738 includes other patents related to pharmaceutical compositions and topical eye treatments. For instance, patents involving liquid vehicles with densities higher than aqueous physiological fluids also play a role in the broader context of eye care treatments[5].

Industry Trends

The pharmaceutical industry is increasingly focused on innovative formulations and delivery methods, especially for eye treatments. The use of semifluorinated compounds represents a cutting-edge approach in this field, highlighting the ongoing research and development in creating effective and safe treatments for eye conditions.

Regulatory Environment

The regulatory environment, particularly the FDA's guidelines and requirements, is crucial for the approval and commercialization of pharmaceutical products. Patents like US Patent 11,357,738 must comply with stringent regulatory standards, including those related to the content of labeling, clinical trials, and postmarketing reporting requirements[4].

Impact on Innovation

Encouraging Innovation

The granting of patents like US Patent 11,357,738 encourages innovation by providing inventors with exclusive rights to their inventions. This protection allows companies to invest in research and development, knowing that their intellectual property will be safeguarded.

Licensing and Litigation

However, broad or unclear claims can lead to increased licensing and litigation costs, potentially hindering innovation. The specific and clear claims in US Patent 11,357,738 mitigate these risks, ensuring that the patent does not impede but rather fosters further innovation in the field.

Market and Commercial Implications

Market Potential

The market potential for semifluorinated compounds in eye treatments is significant, given the growing demand for effective and safe treatments. Patents like US Patent 11,357,738 can provide a competitive edge to companies holding these rights, enabling them to capture a substantial share of the market.

Commercialization

Commercialization of the patented compositions will involve compliance with FDA regulations, including clinical trials and postmarketing surveillance. The clear and specific claims of the patent will facilitate this process, ensuring that the product meets the necessary standards for approval and market entry[4].

Expert Insights

"Patent scope is one of the important aspects in the debates over ‘patent quality.’ Narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims."[3]

This insight from patent experts underscores the importance of well-defined claims in patents like US Patent 11,357,738.

Statistics and Data

  • Patent Maintenance Payments: Patents with narrower claims tend to have lower maintenance payments, indicating a more streamlined and efficient patent process[3].
  • Forward Citations: The number of forward citations can indicate the impact and relevance of a patent. US Patent 11,357,738, with its specific and clear claims, is likely to attract significant forward citations, reflecting its influence in the field.

Conclusion

US Patent 11,357,738 represents a significant advancement in the use of semifluorinated compounds for topical eye treatments. The patent's scope, defined by its clear and specific claims, ensures its validity and enforceability. The broader patent landscape and regulatory environment highlight the importance of this invention in the pharmaceutical industry.

Key Takeaways

  • Specific Claims: The patent's claims are clear and specific, ensuring the patent's validity and enforceability.
  • Regulatory Compliance: The patent must comply with FDA regulations, including clinical trials and postmarketing reporting.
  • Market Potential: The market potential for semifluorinated compounds in eye treatments is substantial.
  • Innovation: The patent encourages innovation by providing exclusive rights to the inventors.
  • Commercialization: Commercialization will involve compliance with FDA regulations and leveraging the competitive edge provided by the patent.

FAQs

Q: What is the primary focus of US Patent 11,357,738?

A: The primary focus is on compositions comprising semifluorinated compounds for topical administration to the eye.

Q: How are the claims in US Patent 11,357,738 characterized?

A: The claims are clear and specific, which is indicative of a well-defined and valid patent.

Q: What is the significance of claim length and count in patent analysis?

A: Narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and shorter examination processes.

Q: How does the regulatory environment impact the commercialization of the patented compositions?

A: The regulatory environment, particularly FDA guidelines, requires compliance with clinical trials, labeling, and postmarketing reporting, which is crucial for market entry.

Q: What is the market potential for semifluorinated compounds in eye treatments?

A: The market potential is significant due to the growing demand for effective and safe eye treatments.

Sources

  1. US Patent 11,357,738 - Semifluorinated compounds and their compositions[1].
  2. PharmaCompass - US Patent 11357738 | Expiry | Expiration[2].
  3. Hoover Institution - Patent Claims and Patent Scope[3].
  4. FDA Regulations - Reporting Requirements and Clinical Trials[4].
  5. Unified Patents Portal - Pharmaceutical compositions based on liquid vehicles[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,357,738

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.